S Biomedics Co Ltd
KOSDAQ:304360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of S Biomedics Co Ltd (304360) under the Base Case is KRW per share. Compared with the current market price of 17 710 KRW, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 3 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What S Biomedics Does
S Biomedics Co Ltd is a South Korean biotech company that develops cell therapies and stem-cell based medicines. Its work focuses on treating serious diseases where standard drugs often do little, such as nerve, eye, and other degenerative conditions. The company turns lab-grown cells into therapies that can be tested in patients and, if approved, used in hospitals.
- Headquarters
- Korea KR
- Employees
- 54
- IPO date
- May 4, 2023
Earnings Waterfall
S Biomedics Co Ltd
What is the Intrinsic Value of one S Biomedics Co Ltd stock?
The intrinsic value for S Biomedics Co Ltd (304360) under the Base Case is KRW.
Is S Biomedics Co Ltd stock undervalued or overvalued?
Compared with the current market price of 17 710 KRW, the stock appears .